Tekla Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $12.7M | Buy |
58,577
+5,125
| +10% | +$1.11M | 0.5% | 47 |
|
2023
Q1 | $9.71M | Hold |
53,452
| – | – | 0.37% | 57 |
|
2022
Q4 | $10.5M | Buy |
53,452
+29,836
| +126% | +$5.86M | 0.4% | 56 |
|
2022
Q3 | $5.31M | Sell |
23,616
-55,441
| -70% | -$12.5M | 0.22% | 74 |
|
2022
Q2 | $10M | Sell |
79,057
-21,401
| -21% | -$2.71M | 0.39% | 61 |
|
2022
Q1 | $12.7M | Hold |
100,458
| – | – | 0.45% | 54 |
|
2021
Q4 | $13.2M | Hold |
100,458
| – | – | 0.42% | 55 |
|
2021
Q3 | $12.3M | Hold |
100,458
| – | – | 0.4% | 61 |
|
2021
Q2 | $11.5M | Buy |
100,458
+15,222
| +18% | +$1.74M | 0.37% | 72 |
|
2021
Q1 | $10.2M | Hold |
85,236
| – | – | 0.35% | 73 |
|
2020
Q4 | $8.66M | Buy |
85,236
+43,409
| +104% | +$4.41M | 0.3% | 91 |
|
2020
Q3 | $3.23M | Buy |
41,827
+11,954
| +40% | +$924K | 0.12% | 123 |
|
2020
Q2 | $3.33M | Buy |
+29,873
| New | +$3.33M | 0.13% | 130 |
|